John J. Reddington, Ph.D., DVM, will step down in February as president and CEO of the study-funding organization Morris Animal Foundation.
Dr. Reddington’s decision to retire after 20 months on the job was announced Jan. 30.
“We greatly appreciate the impact that Dr. Reddington has had on the foundation during his tenure,” said Walt George, chairman of the Morris Animal Foundation board of trustees. “We wish Dr. Reddington all the best in his well-deserved retirement and look forward to having him in an advisory role during the upcoming transition.”
Tiffany Grunert, who joined Morris in March 2017 as vice president of marketing and brand strategy, was named acting president and CEO while the trustees search for Dr. Reddington’s successor.
“During this transition, we’ll continue to focus on our highly respected scientific programs while ensuring the support systems for those programs stay focused and strong,” Grunert said.
The Denver-based foundation thanked Dr. Reddington for his contributions, which began with his hiring in May 2016.
“Dr. Reddington has overseen continued excellence in the organization’s core scientific programs, including expansion into new areas such as biometrics and data analysis, and significant enhancements to its communications, financial portfolio performance and fundraising efforts,” Morris stated.
He worked for many years as an executive at animal and human health companies such as Cambridge Biomedical Inc., Sirtex Medical Inc. and Urigen Pharmaceuticals Inc.
Grunert moved to Morris from the Denver Zoological Foundation, where she served as vice president of external relations.